Rio

top 5: $ABVX $RKLB $ASTS $NKTR $QS

[Rio @riocybin]

@pagayaland Did you look into Rocket Lab?

[Rio @riocybin]

@Taintslapp12283

[Rio @riocybin]

@lookoutitsbbear @KlonnyPin_Gosch Wtf! What’s the efta number?

[Rio @riocybin]

@henwil231 Let’s see where they are headed. The jet initially departed from Doha, if I’m not mistaken.

[Rio @riocybin]

@LogicalThesis Exactly, I got back into Nektar AFTER the data dropped for $38/share. Wtf?

[Rio @riocybin]

@kingtutcap Who knows what else the doj is still hiding. Too many musk fans are still in the denial stage.

[Rio @riocybin]

@unemon1 Nobody seems to realize that Merck has a significant presence in Paris under the name MSD

[Rio @riocybin]

@anandragn @RealSimpleAriel “It wasn’t there, when I checked” doesn’t mean he never posted it. He did.

[Rio @riocybin]

@Oldtimertrades @pennycheck He cares a lot, this is what he wants.

[Rio @riocybin]

@PickingMyOwn Long $ABVX is contrarian now apparently lol. Just buy and chill.

[Rio @riocybin]

@AlexfromBabylon You’re alluding to Mobileye, I suppose. Glad, I stayed away up until now, but I’m intrigued at the current mcap.

[Rio @riocybin]

@seedy19tron You must be at around 65% weight in abivax by now, right?

[Rio @riocybin]

@divkraft Well, it’s out on the ecco website

[Rio @riocybin]

$ABVX

Fibrosis data from ECCO 26 (Abstract OP30):

In vivo (mice): ~52% reduction in collagen (early), ~42% (late) vs ~24% control.

In vitro (human cells): 50% reduction in PRO-C3; active in pathways where Nintedanib showed no activity.
Stat sig: p < 0.0001 for key markers.

[Rio @riocybin]

@Colecalciferol1 Where’s the part that hasn’t been known?
$ABVX

[Rio @riocybin]

@A_May_MD @WallStSai @Biohazard3737 Caveat: “As long as it’s complementary to our own assets, then we can go very big in buying something in.”

[Rio @riocybin]

@Oligo_bio Now I don’t know his current net worth, but no rational human being risks a guaranteed $200 million fortune on the hopes that a drug launch goes perfectly in 2027…

[Rio @riocybin]

@LogicalThesis Might just be setting up for next leg

[Rio @riocybin]

@plantmath1 It’s not over. Many names in Europe still setting up. It’s just starting to dawn on everyone that decoupling from the US shouldn’t be a process, it has to happen ASAP.

[Rio @riocybin]

Being contrarian for the sake of being contrarian is not a thesis. Some of my greatest hits seemed too good to be true initially, like $RKLB at 3 billion mcap.

Mindless pumpers don’t just pump gme or amc, they pump great companies, too. Best to just ignore them.

$ABVX

[Quant Bro @Quantbro1]

I see too much hype with $abvx. Everyone is saying it’s going to get bought out at $200 a share and these unrealistic prices. I don’t think the system is going to let people make money this easy. When people say it’s too good to be true, it is too good to be true (for 98% of the time). I wouldn’t be surprised if this is all a dud.

[Rio @riocybin]

@SaintEquitie @BiotechTV Some time ago he said he’d soon elaborate on how J&Js IL-23 could increase the TAM for Obe